You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
ACAD10 or ACADM or ACADS or ACAD8 or ACAD9 or ACADSB or ACAD11
Uniprot says ACAD10 can only act on (R)- and (S)-2-methyl-pentadecanoyl-CoA, citing this paper. From the end of the paragraph under the section heading "Prokaryotic expression of ACAD10 and ACAD11" of that paper:
Extracts from cells expressing a predicted mature mitochondrial ACAD10 insert were only active with R and S, 2 methyl-C15-CoA (R and S, 2-methyl-pentadecanoyl-CoA) among a broad series of other substrates including the optimum ones for all of the other ACADs. The measured activity (1.4 mU/mg at 150 μM substrate concentration) is considerably lower than that obtained with other expressed ACADs towards their optimum substrates, suggesting that the dehydrogenation reaction between ACAD10 and R or S, 2 methyl-C15-CoA is unlikely the optimal function for ACAD10 in vivo.
I can't seem to find any other papers that ever showed that ACAD10 can act on propanoyl-CoA, butyryl-CoA, or anything else. Also Human-GEM does not already seem to have a metabolite for 2-methyl-pentadecanoyl-CoA; the closest I can find is pristanoyl-CoA (MAM00078x), i.e. 2,6,10,14-tetramethylpentadecanoyl-CoA, but that's known to be oxidized by peroxisomal beta-oxidation (source), and ACAD10 seems to be localized to mitochondria, or at least not localized to peroxisomes (source).
I think ACAD10 should be removed from the GPRs of MAR03212 and MAR03163 and also removed from Human-GEM altogether.
This is slightly redundant with the proposed changes in #634, since both reactions are also associated with ACAD11, which is localized to peroxisomes, but the metabolites are all mitochondrial, and #634 proposes new GPRs that only contain genes that code for mitochondrial proteins known to catalyze this kind of reaction.
The text was updated successfully, but these errors were encountered:
@Devlin-Moyer thanks for collecting the evidence, in which the statement "ACAD10 insert were only active with R and S, 2 methyl-C15-CoA among a broad series of other substrates including the optimum ones for all of the other ACADs" supports the removal of MAR03212 and MAR03163, as well as Human-GEM
When working on #726, I noticed that ACAD10 (
ENSG00000111271
) is currently associated with only two reactions in Human-GEM:Uniprot says ACAD10 can only act on (R)- and (S)-2-methyl-pentadecanoyl-CoA, citing this paper. From the end of the paragraph under the section heading "Prokaryotic expression of ACAD10 and ACAD11" of that paper:
I can't seem to find any other papers that ever showed that ACAD10 can act on propanoyl-CoA, butyryl-CoA, or anything else. Also Human-GEM does not already seem to have a metabolite for 2-methyl-pentadecanoyl-CoA; the closest I can find is pristanoyl-CoA (
MAM00078x
), i.e. 2,6,10,14-tetramethylpentadecanoyl-CoA, but that's known to be oxidized by peroxisomal beta-oxidation (source), and ACAD10 seems to be localized to mitochondria, or at least not localized to peroxisomes (source).I think ACAD10 should be removed from the GPRs of
MAR03212
andMAR03163
and also removed from Human-GEM altogether.This is slightly redundant with the proposed changes in #634, since both reactions are also associated with ACAD11, which is localized to peroxisomes, but the metabolites are all mitochondrial, and #634 proposes new GPRs that only contain genes that code for mitochondrial proteins known to catalyze this kind of reaction.
The text was updated successfully, but these errors were encountered: